The goal of this activity is for learners to be better able to identify the latest clinical evidence and insights on drug-induced PAH including the mechanisms, risk factors, diagnosis, and management to provide optimal patient care.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/pulmonary-hypertension-virtual-patient-encounters-2024a1000iky
- Start Date: 2024-10-15 05:00:00
- End Date: 2024-10-15 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Actelion Pharmaceuticals - Amount: 64784.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 27353.0 - Is Kind Support: False Source: United Therapeutics - Amount: 14396.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cardiovascular Disease, Internal Medicine, Pulmonary Disease
Subscribe
Login
0 Comments
Oldest